NCT05493527

Brief Summary

A randomized controlled trial comparing Noninvasive high frequency oscillatory ventilation (NHFOV) and Noninvasive positive pressure ventilation (NIPPV) as post-extubation respiratory support in preterm neonates with respiratory distress syndrome(RDS)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

August 3, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 9, 2022

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2022

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2022

Completed
Last Updated

August 9, 2022

Status Verified

August 1, 2022

Enrollment Period

1.5 years

First QC Date

August 3, 2022

Last Update Submit

August 7, 2022

Conditions

Keywords

noninvasive high frequency ventilationnoninvasive ventilationRDSpost-extubationpretermrespiratory distress syndromenoninvasive positive pressure ventilation

Outcome Measures

Primary Outcomes (1)

  • Re-intubation rate

    Percentage of Patients who failed weaning on the assigned noninvasive mode and needed reintubation to the total number of patients assigned to that mode.

    72 hours

Secondary Outcomes (16)

  • Days on the assigned non-invasive respiratory support

    8 weeks or till patient discharge which comes first

  • Days on supplemental oxygen

    8 weeks or till patient discharge which comes first

  • Duration of admission

    8 weeks or till patient discharge which comes first

  • Mortality rate

    8 weeks or till patient death which comes first

  • Lung ultrasound score

    Before extubation and after 2 hours on assigned mode

  • +11 more secondary outcomes

Study Arms (2)

noninvasive high frequency oscillatory ventilation (NHFOV)

EXPERIMENTAL

After documenting parental consent, the ventilated infants eligible for extubation were randomly assigned to NHFOV as post extubation noninvasive respiratory support

Device: noninvasive high frequency oscillatory ventilation

noninvasive positive pressure ventilation (NIPPV)

ACTIVE COMPARATOR

After documenting parental consent, the ventilated infants eligible for extubation were randomly assigned to NIPPV as post extubation noninvasive respiratory support

Device: noninvasive positive pressure ventilation

Interventions

A time-cycled, pressure-limited, and continuous-flow neonatal ventilator (SLE6000; SLE) was used for neonates assigned to the NHFOV group. The settings were as follows: 1. a frequency of 10 Hertz ( range, 8-12 Hz); 2. an inspiratory time of 50% (1:1) 3. an oscillation amplitude of 35 centimeter of water column (cmH2O) (subsequent regulation range, 20-40 cmH2O) Oscillation amplitude would be regulated according to the level of carbon dioxide(CO2). Visible chest oscillation was not necessary because elimination of CO2 during NHFOV could also occur in the upper respiratory airway dead space 4. Mean airway pressure (MAP) of 10 cm H2O ( range, 7-15) MAP was regulated according to an open lung recruitment strategy 5. fraction of inspired oxygen (FIO2) regulated from 0.21 to 0.40 in order to maintain saturation from 90% to 95% as determined with a pulse oximeter.

noninvasive high frequency oscillatory ventilation (NHFOV)

NIPPV will be delivered by ventilator generating the targeted pressures. Infants will be on: 1. Peep ranging from 5 to 10 cmH2O, 2. Peak inspiratory pressure range 15-25 cmH2O 3. Rate range 40-50 breath/minute 4. FIO2 regulated from 0.21 to 0.40 in order to maintain saturation from 90% to 95% as determined with a pulse oximeter.

noninvasive positive pressure ventilation (NIPPV)

Eligibility Criteria

Age1 Minute - 1 Month
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preterm neonates with gestational age ≤ 35 weeks.
  • Neonates that were on invasive mechanical ventilation for at least 48 hours eligible for extubation

You may not qualify if:

  • Patients with major upper or lower airway anomalies.
  • Patients with significant congenital anomalies including cardiac, abdominal or respiratory.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neonatal Intensive Care Units (NICUs), Ain Shams University

Cairo, Abbasia, 11517, Egypt

RECRUITING

MeSH Terms

Conditions

Infant, Premature, DiseasesDiseaseRespiratory Tract DiseasesPremature BirthRespiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPathologic ProcessesPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesLung DiseasesRespiration Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

August 3, 2022

First Posted

August 9, 2022

Study Start

February 1, 2021

Primary Completion

August 15, 2022

Study Completion

August 30, 2022

Last Updated

August 9, 2022

Record last verified: 2022-08

Locations